Skip to main content
US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
Verdict split
57 compliant 8% 87 non-compliant 12% 611 no verdict yet 81%

151 screened by our own engine against published ratio methodologies computed from primary filings · 50 carrying a reviewed third-party provider verdict.
Classified under Healthcare.

Do the standards agree here?

The seven standards HTR computes reach different verdicts on 92 of the 498 Biotechnology issuers that more than one of them can decide — 18%.

A split is one issuer at least one standard passes and at least one fails. Why they disagree is mostly the denominator each standard measures debt against, not the ceiling.

Screened issuers

Compliant first, then the other verdicts, then the issuers with no verdict yet; alphabetical within each. Every row links to that issuer's full ratio breakdown, business-activity screen and the filing behind it.

IssuerVerdictScreenedSource
Showing 201–300 of 755

Keep going